Trastuzumab Deruxtecan in HER2-Low Breast Cancer. Reply. Modi S, Gambhire D, Cameron D. N Engl J Med 2022;387:1145-1146.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Modi S, Gambhire D, Cameron D. Trastuzumab Deruxtecan in HER2-Low Breast Cancer. Reply. N Engl J Med 2022;387:1145-1146.
PMID: 36130006